HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions

Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, Eleftherios Zachariou, Dimitra Pliakou, Katerina Papakonstantinou, Theofanis Floros, Evangelia Pliakou, Gaetano Riemma · 2024

Read HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions by Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, Eleftherios Zachariou, Dimitra Pliakou, Katerina Papakonstantinou, Theofanis Floros, Evangelia Pliakou, Gaetano Riemma (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11728157.txt.

Description

Dimitrios Papageorgiou and co-authors review, in a 2024 paper, current treatment for an aggressive womb cancer marked by high levels of the HER2 protein. Serous endometrial cancer spreads early and carries a poor outlook compared with the common form. About a third of these tumors overproduce HER2, a growth signal receptor found on many cancers. That marker opens the door to drugs built to block it.

The review gathers trial evidence on pairing standard chemotherapy with HER2 blockers, chiefly trastuzumab, alone or with a partner drug. Such combinations have entered international guidelines. Newer options include antibody-drug conjugates and small-molecule blockers, both under study. The authors also flag drug resistance, whose roots in this cancer stay poorly understood, and trials testing earlier use of the targeted drugs.

Catalog record

CREATORDimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, Eleftherios Zachariou, Dimitra Pliakou, Katerina Papakonstantinou, Theofanis Floros, Evangelia Pliakou, Gaetano Riemma
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11728157

Browse the full library · About the Tower of Babel